News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
191 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17924)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
3 (174)
4 (196)
5 (152)
6 (138)
7 (132)
10 (173)
11 (190)
12 (195)
13 (179)
14 (120)
17 (191)
18 (169)
19 (124)
20 (132)
21 (92)
24 (114)
25 (141)
26 (131)
27 (156)
28 (104)
31 (211)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Drug Development
Cell Therapeutics, Inc. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin’s Lymphoma
March 17, 2008
·
5 min read
Gene Variant Increases Breast Cancer Risk, German Cancer Research Center (DKFZ) Study
March 17, 2008
·
1 min read
BioForest
enGene, Inc. Completes US$6.4M Series A Financing
March 17, 2008
·
1 min read
Drug Development
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Expands IBD Franchise with Addition of New Development Candidate
March 17, 2008
·
4 min read
Drug Development
Arena Pharmaceuticals, Inc. Says Safety Board Clears Obesity Drug Trial
March 17, 2008
·
8 min read
Biotech Bay
Exelixis, Inc. Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
March 17, 2008
·
1 min read
Pharm Country
Sanofi-Aventis (France) New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
March 17, 2008
·
5 min read
Drug Development
deCODE genetics, Inc. Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
March 17, 2008
·
4 min read
FDA
Amgen and Wyeth Announce Enbrel Drug Gets Black Box Infection-Risk Warning
March 17, 2008
·
15 min read
Drug Development
FDA Indicates That Genta Incorporated’s Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data
March 17, 2008
·
7 min read
Previous
19 of 20
Next